WATSON TO PAY $70 MIL. UP FRONT FOR HMR's RUGBY GENERIC DIVISION; HOECHST DIVESTING GENERIC DIVISIONS BEFORE NYSE LISTING SCHEDULED FOR SEPT. 24
Watson Pharmaceuticals is paying $70 mil. up front to acquire the Rugby generic business from Hoechst Marion Roussel, the companies announced Aug. 26.
You may also be interested in...
Hoechst has completed its exit from the generic pharmaceutical industry by agreeing to sell its stake in Copley to Teva-USA for $114 mil.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011